FOSAMAX FEMUR INJURIES - DON’T WAIT UNTIL IT BREAKS
In the past few weeks, our Fosamax femur fracture lawyers have been writing feverishly about the increasing awareness of the public regarding the devastating effects of taking Fosamax (or its generic counterparts, e.g., those manufactured by Teva Pharmaceuticals) over a long period of time. Touted as a wonder drug for the prevention or retardation of osteoporosis (especially in pre- and post-menopausal women), it turns out that scores of women have already reported in medical centers, located in the United States and Canada, that they have sustained low energy fractures of their femur bones, snapping with little or no activity. Merck, the manufacturer of Fosamax, which held an exclusive patent on the formulation until 2008, denies that there is any link.
ABC News and Good Morning America (as well as several other local and regional news agencies) have now reported the concern that these terrible effects may occur from the use of Fosamax. Met with such reports the FDA is investigating whether doctors and the public should be warned by Merck. In the most recent report aired on March 9, 2010, Dr. Richard Besser advised women who are taking Fosamax or generic alendronate, who begin experiencing pain in their thigh to see their doctors immediately. A complete fracture may be around the corner. Even in the absence of such a warning sign, they should ask their doctors if they should remain on Fosamax. A link to the Good Morning America show may be found at:
The product injury lawyers at Pomerantz Perlberger & Lewis, who represent plaintiffs who have suffered femur fractures after long-term use of Fosamax, stand ready to provide additional information and guidance, with helpful resources appearing on their website concerning Fosamax femur fractures.
